NCT03029182

Brief Summary

The study will evaluate the utility of hypoxic exercise training to improve cardiovascular and metabolic health among obese breast cancer survivors. While participants exercise, a lower fraction of inspired oxygen will be used to simulate a higher altitude. This approach removes the mechanical strain needed to sustain moderate-to-vigorous exercise intensity which is believed to support exercise tolerance. Participants are randomized to either the treatment (walking+simulated-altitude) or control (walking under normoxic conditions).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 24, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

May 14, 2018

Status Verified

May 1, 2018

Enrollment Period

1.4 years

First QC Date

January 12, 2017

Last Update Submit

May 7, 2018

Conditions

Keywords

ExerciseCancerObesity

Outcome Measures

Primary Outcomes (3)

  • Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on retention.

    number of participants completing the 8 week session

    baseline to 8 weeks

  • Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on adherence to exercise compliance.

    mean compliance among all participantswith exercise prescription

    baseline to 8 weeks

  • Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on number of adverse events.

    Number of adverse events in each group

    baseline to 8 weeks

Secondary Outcomes (11)

  • The effect sizes for walking+simulated-altitude and walking (control) as measured by a 6 minute walk.

    baseline to 8 weeks

  • The effect sizes for walking+simulated-altitude and walking (control) as measured by the cardiorespiratory fitness.

    baseline to 8 weeks

  • The effect sizes for walking+simulated-altitude and walking (control) as measured by arterial elasticity.

    baseline to 8 weeks

  • The effect sizes for walking+simulated-altitude and walking (control) as measured by resting heart rate variability.

    baseline to 8 weeks

  • The effect sizes for walking+simulated-altitude and walking (control) as measured by the fasting glucose.

    baseline to 8 weeks

  • +6 more secondary outcomes

Study Arms (2)

Walking+simulated-altitude

EXPERIMENTAL

8-week exercise training program that involves 3 supervised, treadmill walking sessions each week with 16% oxygen, which will be administered through an exercise mask.

Other: Walking+simulated-altitude

Walking (control)

ACTIVE COMPARATOR

8-week exercise training program that involves 3 supervised, treadmill walking session each week.

Behavioral: Walking (control)

Interventions

Participants will walk on a treadmill for up to 50 minutes at a 16% oxygen level (administered via exercise mask), which is similar in altitude to Flagstaff, AZ. The progression of exercise training will be based on a varying percents of heart rate reserve.

Walking+simulated-altitude

Participants will walk on a treadmill for up to 50 minutes.The progression of exercise training will be based on a varying percents of heart rate reserve.

Walking (control)

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physician's medical clearance for participation
  • English-speaking women
  • years of age with a history of Stage 0-III breast cancer
  • Preferred walking speed of less than 2.9 mph as measured by a timed 10 meter walk test (to be performed on-site after consent during preliminary screening) "OR" the inability to complete a 6-minute walk without stopping (to be performed on-site after consent during preliminary screening)
  • Body mass index between 30-45 kg/m2
  • ≥1 year post-treatment and not currently receiving or planning to receive chemo/radiation therapies
  • Not participating in a structured exercise routine
  • In the previous 6 months, not engaging in (on average) ≥60 minutes of moderate or ≥30 minutes of vigorous physical activity per week.

You may not qualify if:

  • Males
  • Dementia
  • Medical, psychological, and/or social characteristics that may interfere with the ability to fully participate in the proposed study activities/assessments (e.g., psychosis, schizophrenia)
  • Contraindication to participate in regular exercise training
  • Unwilling to complete prescribed exercise
  • Inability to walk
  • Pregnant
  • Resting oxygen saturation via pulse oximetry below 90%
  • Using home oxygen therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

ObesityBreast NeoplasmsMotor ActivityNeoplasms

Interventions

Walking

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavior

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 24, 2017

Study Start

October 1, 2016

Primary Completion

March 1, 2018

Study Completion

April 1, 2018

Last Updated

May 14, 2018

Record last verified: 2018-05

Locations